BlackRock Group LTD - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 86 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Group LTD ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$66,000
+3.1%
6,994
+5.7%
0.00%
Q3 2016$64,000
+48.8%
6,616
+2.5%
0.00%
Q2 2016$43,000
-25.9%
6,454
-0.9%
0.00%
Q1 2016$58,000
+41.5%
6,511
+107.9%
0.00%
Q4 2015$41,000
+20.6%
3,132
-2.3%
0.00%
Q3 2015$34,000
-26.1%
3,207
+88.0%
0.00%
Q2 2015$46,000
-99.4%
1,706
-99.2%
0.00%
-100.0%
Q4 2014$7,857,000
-2.6%
209,917
-9.1%
0.00%
-20.0%
Q3 2014$8,065,000
-25.2%
230,817
-0.3%
0.01%
-16.7%
Q2 2014$10,777,000
+156.5%
231,517
+70.2%
0.01%
+100.0%
Q1 2014$4,202,000
+119.8%
136,017
+63.1%
0.00%
+200.0%
Q4 2013$1,912,00083,4000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders